Items where Author is "Duparc, S."

Yes

Vignier, N. and Bouchaud, O. and Angheben, A. and Bottieau, E. and Calleri, G. and Salas-Coronas, J. and Martin, C. and Ramos, J. M. and Mechain, M. and Rapp, C. and Nothdurft, H. D. and Velasco, M. and Bardaji, A. and Rojo-Marcos, G. and Visser, L. G. and Hatz, C. and Bisoffi, Z. and Jelinek, T. and Duparc, S. and Bourhis, Y. and Tommasini, S. and Iannucelli, M. and Bacchieri, A. and Mattera, G. G. and Merlo Pich, E. and Behrens, R. H.. (2021) Longitudinal study based on a safety registry for malaria patients treated with artenimol-piperaquine in six European countries. Malar J, 20. p. 214.

Moehrle, J. J. and Duparc, S. and Siethoff, C. and van Giersbergen, P. L. and Craft, J. C. and Arbe-Barnes, S. and Charman, S. A. and Gutierrez, M. and Wittlin, S. and Vennerstrom, J. L.. (2013) First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials. British journal of clinical pharmacology, Vol. 75, H. 2. pp. 535-548.